Breakeven Is Near for ADMA Biologics, Inc. (NASDAQ:ADMA)
We feel now is a pretty good time to analyse ADMA Biologics, Inc.'s (NASDAQ:ADMA) business as it appears the company may be on the cusp of a considerable accomplishment. ADMA Biologics, Inc., a biop
Simply Wall StMay 7 08:53 ET
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
Conference Call Scheduled for May 9, 2024, at 4:30 p.m. ETRAMSEY, N.J. and BOCA RATON, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA" or the "Company"), an end-to
ADMA BiologicsMay 2 00:00 ET
Beat the Market the Zacks Way: ADMA Biologics, Carlisle, McCormick Manufacturing in Focus
Yahoo FinanceApr 29 08:16 ET
We Think ADMA Biologics (NASDAQ:ADMA) Is Taking Some Risk With Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to rui
Simply Wall StApr 22 08:07 ET
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note
Yahoo FinanceApr 19 17:45 ET
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
Yahoo FinanceApr 17 17:50 ET
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
Yahoo FinanceApr 10 10:59 ET
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
Yahoo FinanceApr 9 13:34 ET
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
Yahoo FinanceApr 8 23:38 ET
AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors
Yahoo FinanceApr 8 09:21 ET
J&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio
Yahoo FinanceApr 8 09:18 ET
Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
Yahoo FinanceApr 4 13:20 ET
Here's Why Amgen (AMGN) Stock Is Outperforming the Industry
Yahoo FinanceApr 3 11:14 ET
Bristol Myers (BMY) Wins EC Nod for Reblozyl Label Expansion
Yahoo FinanceApr 3 09:14 ET
Kaitlin Kestenberg Promoted to COO at ADMA Biologics
TipRanksApr 2 17:32 ET
AstraZeneca (AZN) Dato-DXd Breast Cancer BLA Gets FDA Acceptance
Yahoo FinanceApr 2 09:15 ET
AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
Yahoo FinanceApr 2 09:04 ET
Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key Insights
Yahoo FinanceApr 1 17:50 ET
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Yahoo FinanceApr 1 12:46 ET
Investors in ADMA Biologics (NASDAQ:ADMA) Have Seen Splendid Returns of 261% Over the Past Three Years
Yahoo FinanceApr 1 11:09 ET
No Data
No Data